Last week, the California Assembly Appropriations Committee unanimously passed Assembly Bill 228. This week, CV Sciences, a Las Vegas-area cannabis company, announced its full support of the committee’s decision; a move that seems to be working in favor of CVSI stock.
Here’s what we know.
CVSI Stock: The LatestIt’s not surprising to see CVSI stock trading up after CV Sciences (OTCQB:CVSI) announced its support for Assembly Bill 228. Last week, the California Assembly Appropriations Committee passed Assembly Bill 228, which, according to Yahoo Finance, permits the retail sale of hemp-derived cannabidiol in supplements ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.